EXSIGHT VENTURES
  • Home
  • Companies
  • Team
  • Blog
  • Contact
  • Thesis

Exsight partner alan spiro joins innovative odylia therapeutics

9/17/2018

0 Comments

 
Alan is on the Board of Advisors of Odylia Therapeutics.  Odylia has created a novel paradigm to catalyze the development of gene therapies for rare blinding inherited retinal diseases (IRDs).  Its strategy is to provide a non-profit platform that can achieve significant discounts, efficiencies and economies of scale, so as to lower the costs and accelerate the development of treatments for IRDs from the lab through clinical trials.
Scientists, Advocates Team Up to Launch Odylia Therapeutics to Accelerate Gene Therapy Trials for Rare Conditions Causing Blindness
​
New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases.
Boston, Mass. — Scientists and advocates today announced the formation of Odylia Therapeutics, a nonprofit corporation dedicated to creating gene therapies for ultra-rare genetic conditions causing blindness. The company’s efforts will concentrate on developing laboratory findings into human clinical trials for select diseases, addressing an unmet need for drug development in an area where there is currently little commercial interest. Odylia Therapeutics is being launched with support from Massachusetts Eye and Ear and the Usher 2020 Foundation, a charitable organization focused on finding cures for rare eye diseases. Read the full release here. 


0 Comments



Leave a Reply.

    Author

    ExSight Ventures

    Archives

    January 2021
    December 2020
    August 2020
    July 2020
    June 2020
    February 2020
    December 2019
    October 2019
    August 2019
    July 2019
    February 2019
    September 2018
    August 2018
    July 2018

    View my profile on LinkedIn

    Categories

    All

    RSS Feed

 ©ExSight Ventures, LLC                    Privacy Policy                    Terms and Conditions          Disclaimer       
  • Home
  • Companies
  • Team
  • Blog
  • Contact
  • Thesis